Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer

被引:60
作者
Hsu, Yi-Hsin [1 ]
Yao, Jun [1 ]
Chan, Li-Chuan [1 ,2 ]
Wu, Ting-Jung [1 ,3 ]
Hsu, Jennifer L. [1 ,4 ,5 ,6 ]
Fang, Yueh-Fu [1 ,7 ]
Wei, Yongkun [1 ]
Wu, Yun [8 ]
Huang, Wen-Chien [9 ]
Liu, Chien-Liang [9 ]
Chang, Yuan-Ching [9 ]
Wang, Ming-Yang [1 ,10 ]
Li, Chia-Wei [1 ]
Shen, Jia [1 ,2 ]
Chen, Mei-Kuang [2 ]
Sahin, Aysegul A. [8 ]
Sood, Anil [2 ,11 ]
Mills, Gordon B. [2 ,12 ]
Yu, Dihua [1 ,2 ]
Hortobagyi, Gabriel N. [13 ]
Hung, Mien-Chie [1 ,2 ,4 ,5 ,6 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas, Grad Sch Biomed Sci Houston, Houston, TX USA
[3] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Gen Surg, Taipei, Taiwan
[4] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan
[5] China Med Univ, Ctr Mol Med, Taichung, Taiwan
[6] Asia Univ, Dept Biotechnol, Taichung, Taiwan
[7] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Internal Med, Taipei, Taiwan
[8] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[9] Mackay Mem Hosp, Mackay Jr Coll Med Nursing & Management, Dept Surg, Taipei, Taiwan
[10] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan
[11] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[12] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
[13] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
关键词
PROTEIN-KINASE; INHIBITOR OLAPARIB; ANALYSIS TOOL; STEM-CELLS; PHASE-I; COMBINATION; EXPRESSION; SURVIVAL; TRIAL; IDENTIFICATION;
D O I
10.1158/0008-5472.CAN-14-0584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancer (TNBC) is a highly heterogeneous and recurrent subtype of breast cancer that lacks an effective targeted therapy. To identify candidate therapeutic targets, we profiled global gene expression in TNBC and breast tumor-initiating cells with a patient survival dataset. Eight TNBC-related kinases were found to be overexpressed in TNBC cells with stem-like properties. Among them, expression of PKC-alpha. MET, and CHK6 correlated with poorer survival outcomes. In cases coexpressing two of these three kinases, survival rates were lower than in cases where only one of these kinases was expressed. In functional tests, two-drug combinations targeting these three kinases inhibited TNBC cell proliferation and turnorigenic potential in a cooperative manner. A combination of PKC-alpha-MET inhibitors also attenuated tumor growth in a cooperative manner in vivo. Our findings define three kinases critical for TNBC growth and offer a preclinical rationale for their candidacy as effective therapeutic targets in treating TNBC. (C)2014 AACR
引用
收藏
页码:4822 / 4835
页数:14
相关论文
共 49 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]  
[Anonymous], 1958, STAT METHOD EVALUATI
[3]  
[Anonymous], 2009, BOSTON NEWS LETT, DOI DOI 10.1016/J.C0LSURFB.2008.09.014]
[4]   A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair [J].
Ashworth, Alan .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3785-3790
[5]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[6]   Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors [J].
Bendell, Johanna C. ;
Rodon, Jordi ;
Burris, Howard A. ;
de Jonge, Maja ;
Verweij, Jaap ;
Birle, Diana ;
Demanse, David ;
De Buck, Stefan S. ;
Ru, Qinhua C. ;
Peters, Malte ;
Goldbrunner, Michael ;
Baselga, Jose .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :282-290
[7]   High-efficiency blotting of proteins of diverse sizes following sodium dodecyl sulfate-polyacrylamide gel electrophoresis [J].
Bolt, MW ;
Mahoney, PA .
ANALYTICAL BIOCHEMISTRY, 1997, 247 (02) :185-192
[8]   IMMUNOLOGICAL QUANTITATION OF PHOSPHOLIPID/CA-2+-DEPENDENT PROTEIN-KINASE OF HUMAN MAMMARY-CARCINOMA CELLS - INVERSE RELATIONSHIP TO ESTROGEN-RECEPTORS [J].
BORNER, C ;
WYSS, R ;
REGAZZI, R ;
EPPENBERGER, U ;
FABBRO, D .
INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) :344-348
[9]   Triple-negative breast cancer: disease entity or title of convenience? [J].
Carey, Lisa ;
Winer, Eric ;
Viale, Giuseppe ;
Cameron, David ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (12) :683-692
[10]   p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs [J].
Chang, Chun-Ju ;
Chao, Chi-Hong ;
Xia, Weiya ;
Yang, Jer-Yen ;
Xiong, Yan ;
Li, Chia-Wei ;
Yu, Wen-Hsuan ;
Rehman, Sumaiyah K. ;
Hsu, Jennifer L. ;
Lee, Heng-Huan ;
Liu, Mo ;
Chen, Chun-Te ;
Yu, Dihua ;
Hung, Mien-Chie .
NATURE CELL BIOLOGY, 2011, 13 (03) :317-U296